acut
exacerb
viral
infect
b
r
c
background
patient
slowli
progress
idiopath
interstiti
pneumonia
includ
idiopath
pulmonari
fibrosi
often
deterior
thu
suggest
clinic
cours
may
unpredict
episod
term
acut
exacerb
idiopath
interstiti
pneumonia
etiolog
acut
exacerb
idiopath
interstiti
pneumonia
unknown
studi
test
hypothesi
acut
exacerb
idiopath
interstiti
pneumonia
induc
respiratori
viral
infect
method
bronchoalveolar
lavag
fluid
obtain
patient
acut
exacerb
idiopath
interstiti
pneumonia
test
viral
nucleic
acid
use
polymeras
chain
reaction
result
patient
acut
exacerb
idiopath
interstiti
pneumonia
exhibit
evid
respiratori
syncyti
viru
b
patient
exhibit
evid
cytomegaloviru
seven
patient
fulfil
diagnost
criteria
idiopath
pulmonari
fibrosi
conclus
case
acut
exacerb
idiopath
interstiti
pneumonia
caus
viral
infect
idiopath
interstiti
pneumonia
iip
group
diffus
parenchym
lung
diseas
unknown
caus
iip
includ
entiti
idiopath
pulmonari
fibrosi
ipf
nonspecif
interstiti
pneumonia
cryptogen
organ
pneumonia
acut
interstiti
pneumonia
respiratori
bronchiolitisassoci
interstiti
lung
diseas
desquam
interstiti
pneumonia
lymphocyt
interstiti
pneumonia
ipf
common
form
iip
diagnos
basi
clinic
characterist
highresolut
chest
comput
tomographi
find
pulmonari
function
test
physiolog
find
patient
iip
fulfil
criteria
surgic
lung
biopsi
necessari
classifi
iip
particular
type
histopatholog
find
term
usual
interstiti
pneumonia
ipf
involv
heterogen
appear
low
magnif
altern
area
normal
lung
tissu
interstiti
inflamm
fibrosi
honeycomb
chang
although
ipf
gradual
progress
diseas
patient
experi
acut
respiratori
deterior
suggest
clinic
cours
may
unpredict
episod
term
acut
exacerb
ipf
similar
process
acut
unexplain
respiratori
deterior
occur
patient
iip
gener
term
episod
acut
ipf
exacerb
acut
exacerb
iip
although
previou
report
show
reduc
steroid
dose
ipf
treatment
bronchoalveolar
lavag
bal
surgic
treatment
could
induc
acut
exacerb
ipf
etiolog
diseas
unknown
unclear
whether
respiratori
viral
infect
might
induc
acut
iip
exacerb
acut
iip
exacerb
similar
clinic
symptom
highresolut
comput
tomographi
chest
find
viral
pneumonia
poor
sensit
standard
method
viral
detect
studi
test
hypothesi
acut
iip
exacerb
induc
respiratori
viral
infect
collect
bronchoalveolar
lavag
fluid
balf
patient
acut
iip
exacerb
use
polymeras
chain
reaction
pcr
detect
respiratori
virus
materi
method
case
bronchoscopi
perform
part
clinic
evalu
case
respiratori
failur
perform
bronchoscopi
oxygen
supplement
use
noninvas
ventil
bal
perform
segment
subseg
right
middl
lobe
lingual
region
ml
steril
salin
instil
subsequ
balf
analyz
white
blood
cell
count
differenti
viru
separ
increas
percentag
white
blood
cell
assess
base
follow
american
thorac
societi
guidelin
increas
percentag
lymphocyt
neutrophil
eosinophil
respect
viral
separ
perform
srl
tokyo
japan
balf
sampl
use
pcr
store
readi
process
total
deoxyribonucl
acid
dna
ribonucl
acid
rna
extract
balf
sampl
use
qiaamp
minelut
viru
spin
kit
qiagen
tokyo
japan
cdna
synthesi
perform
use
cycleav
pcr
kit
takara
bio
tokyo
japan
accord
manufactur
protocol
summari
revers
transcriptas
rt
perform
eppendorf
tube
contain
reaction
mixtur
compris
aliquot
dnarna
sampl
reaction
mixtur
consist
rt
buffer
mix
contain
buffer
dntp
mixtur
random
primer
takara
bio
shiga
japan
along
primescript
rt
enzym
mix
contain
primescript
rtase
rnase
inhibitor
takara
bio
shiga
japan
final
volum
rt
mixtur
adjust
addit
dnaseand
rnasefre
h
rt
reaction
carri
min
deactiv
rtase
carri
use
thermal
cycler
life
technolog
tokyo
japan
perform
bal
patient
pneumonia
caus
pandem
influenza
treat
balf
synthes
cdna
accord
method
order
examin
valid
techniqu
balf
sampl
posit
pcr
pandem
influenza
pcr
analysi
also
perform
use
cycleav
pcr
kit
patient
characterist
shown
tabl
fourteen
patient
men
exacerb
iip
recruit
seven
patient
fulfil
criteria
ipf
patient
suspect
nonspecif
interstiti
pneumonia
basi
highresolut
chest
comput
tomographi
find
exacerb
patient
treat
immunosuppress
therapi
patient
treat
iipspecif
drug
immunosuppress
drug
pirfenidon
inhal
nacetylcystein
patient
white
blood
cell
count
creactiv
protein
level
level
increas
deviat
sd
mgdl
uml
respect
balf
find
shown
tabl
bal
perform
patient
ml
steril
salin
patient
total
cell
count
increas
ml
percentag
lymphocyt
increas
patient
percentag
neutrophil
increas
patient
percentag
eosinophil
increas
patient
viral
separ
perform
patient
virus
separ
patient
posit
viral
control
human
rhinoviru
cdna
obtain
human
posit
respiratori
virus
balf
posit
rsvb
case
patient
although
balf
posit
cmv
case
patient
tabl
cmv
antigenemia
neg
case
case
present
patient
man
receiv
clinic
diagnosi
ipf
accord
criteria
american
thorac
societi
european
respiratori
societi
intern
statement
march
observ
without
administr
medic
two
day
admiss
high
fever
develop
dri
cough
symptom
worsen
admit
hospit
februari
bodi
temperatur
respir
rate
breathsmin
percutan
oxygen
satur
room
air
physic
examin
fine
crackl
audibl
base
lung
laboratori
find
admiss
follow
white
blood
cell
count
lactat
dehydrogenas
iul
creactiv
protein
mgdl
uml
chest
radiograph
show
featur
diffus
infiltr
lung
field
highresolut
chest
comput
tomographi
show
new
diffus
bilater
groundglass
opac
superimpos
background
reticular
opac
honeycomb
traction
bronchiectasi
basal
peripher
predomin
balf
analysi
reveal
increas
neutrophil
evid
infecti
diseas
patient
treat
steroid
puls
therapi
g
methylprednisolon
per
day
day
antibiot
meropenem
r
e
p
r
r
n
v
e
g
n
pazufloxacin
treatment
highresolut
chest
comput
tomographi
show
improv
groundgrass
opac
steroid
puls
therapi
patient
treat
mg
prednisolon
per
day
prednisolon
taper
month
studi
viral
nucleic
acid
detect
use
pcr
case
acut
exacerb
ipf
investig
studi
occult
respiratori
viral
infect
patient
acut
iip
exacerb
konishi
et
al
use
gene
express
microarray
character
acut
ipf
exacerb
find
gene
express
pattern
indic
respons
lung
viral
infect
huie
et
al
report
perform
bal
patient
present
acut
declin
fibrot
lung
diseas
found
patient
cultur
pcr
evid
viral
infect
parainfluenza
viru
case
herp
simplex
viru
case
cytomegaloviru
infect
case
wootton
et
al
report
balf
serum
obtain
patient
acut
ipf
exacerb
test
viral
nucleic
acid
use
multiplex
pcr
panvir
microarray
high
throughput
cdna
sequenc
studi
patient
acut
ipf
exacerb
exhibit
evid
viral
infect
parainfluenza
viru
case
coronaviru
case
herp
simplex
viru
case
rhinoviru
case
epsteinbarr
viru
case
torqu
teno
viru
case
result
suggest
respiratori
viral
infect
main
caus
acut
ipf
exacerb
rsvb
posit
patient
acut
ipf
exacerb
rsv
infrequ
detect
asymptomat
individu
rsv
infect
usual
associ
clinic
ill
regard
caus
pathogen
detect
patient
respiratori
symptom
rsv
known
caus
acut
lower
respiratori
infect
young
children
rsv
also
common
adult
howev
usual
caus
mild
upper
respiratori
tract
diseas
previou
report
investig
associ
rsv
infect
acut
ipf
exacerb
report
increas
level
circul
proinflammatori
cytokin
interleukin
il
interferon
present
acut
ipf
exacerb
upregul
critic
neutrophil
recruit
balf
patient
acut
ipf
exacerb
character
neutrophilia
hand
vitro
studi
use
human
bronchiolar
epitheli
cell
macrophag
dendrit
cell
describ
complex
network
rsvinduc
stimul
inhibit
proinflammatori
cytokin
rsv
infect
human
bronchiolar
epitheli
cell
lead
product
immun
cellspecif
chemokin
earli
interact
rsv
sever
tolllik
receptor
dendrit
cell
monocyt
releas
proinflammatori
cytokin
tumor
necrosi
result
appear
rsv
infectioninduc
proinflammatori
cytokin
recruit
neutrophil
induc
acut
ipf
exacerb
pcr
cmv
posit
patient
investig
report
occurr
human
herp
viral
shed
alveolar
fluid
patient
acut
stress
cmv
reactiv
infect
patient
admit
intens
care
unit
hand
cmv
report
colon
respiratori
tract
immunocompromis
patient
present
studi
cytomegaloviru
antigenemia
neg
peripher
blood
patient
posit
pcr
cmv
result
suggest
cmv
trigger
exacerb
colon
invert
ratio
seen
patient
posit
result
viral
infect
previou
report
show
invert
ratio
seen
patient
viral
r
e
p
r
r
n
v
e
g
n
pneumonia
hand
increas
ratio
seen
patient
acut
ipf
exacerb
ratio
would
use
assess
viral
infect
import
limit
studi
includ
small
number
patient
possibl
occult
viral
infect
furthermor
perform
bal
acut
exacerb
period
therefor
conclud
viru
question
caus
new
infect
prospect
studi
use
patient
bal
perform
occas
evalu
stabl
iip
acut
iip
exacerb
necessari
summari
use
pcr
method
detect
viral
infect
patient
acut
iip
exacerb
result
studi
suggest
case
acut
iip
exacerb
caus
viral
infect
therefor
studi
necessari
clarifi
whether
rsv
infect
induc
acut
iip
exacerb
